- Home
- STBA vs JANX Comparison
STBA vs JANX Comparison
Compare STBA & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STBA
- JANX
- Stock Information
- Founded
- STBA 1902
- JANX 2017
- Country
- STBA United States
- JANX United States
- Employees
- STBA N/A
- JANX N/A
- Industry
- STBA Major Banks
- JANX Biotechnology: Pharmaceutical Preparations
- Sector
- STBA Finance
- JANX Health Care
- Exchange
- STBA Nasdaq
- JANX Nasdaq
- Market Cap
- STBA 1.5B
- JANX 1.4B
- IPO Year
- STBA N/A
- JANX 2021
- Fundamental
- Price
- STBA $35.82
- JANX $27.01
- Analyst Decision
- STBA Hold
- JANX Strong Buy
- Analyst Count
- STBA 3
- JANX 11
- Target Price
- STBA $42.00
- JANX $76.55
- AVG Volume (30 Days)
- STBA 122.5K
- JANX 927.5K
- Earning Date
- STBA 10-23-2025
- JANX 11-05-2025
- Dividend Yield
- STBA 3.79%
- JANX N/A
- EPS Growth
- STBA N/A
- JANX N/A
- EPS
- STBA 3.40
- JANX N/A
- Revenue
- STBA $388,489,000.00
- JANX $439,000.00
- Revenue This Year
- STBA $7.12
- JANX N/A
- Revenue Next Year
- STBA $5.09
- JANX $91.66
- P/E Ratio
- STBA $10.56
- JANX N/A
- Revenue Growth
- STBA 1.05
- JANX N/A
- 52 Week Low
- STBA $30.84
- JANX $21.73
- 52 Week High
- STBA $45.46
- JANX $71.71
- Technical
- Relative Strength Index (RSI)
- STBA 42.12
- JANX 59.54
- Support Level
- STBA $34.38
- JANX $25.62
- Resistance Level
- STBA $37.18
- JANX $27.70
- Average True Range (ATR)
- STBA 0.88
- JANX 1.56
- MACD
- STBA -0.13
- JANX 0.30
- Stochastic Oscillator
- STBA 39.02
- JANX 69.68
About STBA S&T Bancorp Inc.
S&T Bancorp Inc is a bank holding company. The company operates in five markets including Western Pennsylvania, Eastern Pennsylvania, Northeast Ohio, Central Ohio and Upstate New York. The company provides financial services with retail and commercial banking products, cash management services, trust and brokerage services. It operates only in one segment which is Community Banking. The company earns revenue from interest on loans and securities and fees charged for financial services provided to its customers.
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.